Trials / Conditions / Carcinoma, Merkel Cell
Carcinoma, Merkel Cell
4 registered clinical trials studyying Carcinoma, Merkel Cell — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult NCT07302347 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Recruiting | Studies of Dermatologic Diseases Biospecimen Acquisition Protocol NCT02471352 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | — |
| Completed | Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues NCT02351128 | University Hospital, Grenoble | Phase 2 |
| Completed | Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) NCT02155647 | EMD Serono Research & Development Institute, Inc. | Phase 2 |